Updates to Several Tables in the Adult and Adolescent Opportunistic Infections Guidelines

 

 

 

	OFFERING INFORMATION ON HIV/AIDS TREATMENT, PREVENTION, AND RESEARCH
	At-a-Glance   Issue No. 24 | October 22, 2019 View HTML version     News and Features Updates to Several Tables in the Adult and Adolescent Opportunistic Infections Guidelines The Panel updated the following tables in the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. The updates include information on new drugs added to the guidelines as well as information derived from product labels and published literature since the last revision. Table 5. Significant Pharmacokinetic Interactions between Drugs Used to Treat or Prevent Opportunistic Infections Table 6. Common or Serious Adverse Reactions Associated with Systemically Administered Drugs Used to Treat Opportunistic Infections Table 7. Dosing Recommendations for Drugs Used to Treat or Prevent Opportunistic Infections That Require Dosage Adjustment in Patients with Renal Insufficiency              Home | Guidelines | Understanding HIV/AIDS | Drugs | Clinical Trials | Research Contact Us

 

---

You are subscribed as myhcistech.healthnews360@blogger.com. Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit the GovDelivery Subscriber Help Center at https://insights.govdelivery.com/Communications/Subscriber_Help_Center.

This service is provided to you at no charge by AIDSinfo.

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: AIDSinfo · P.O. Box 4780· Rockville, MD 20849-6303